Cargando…
Epidermolysis bullosa: Advances in research and treatment
Epidermolysis bullosa (EB) is the umbrella term for a group of rare inherited skin fragility disorders caused by mutations in at least 20 different genes. There is no cure for any of the subtypes of EB resulting from different mutations, and current therapy only focuses on the management of wounds a...
Autores principales: | Prodinger, Christine, Reichelt, Julia, Bauer, Johann W., Laimer, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900197/ https://www.ncbi.nlm.nih.gov/pubmed/31140655 http://dx.doi.org/10.1111/exd.13979 |
Ejemplares similares
-
Translational perspectives to treat Epidermolysis bullosa—Where do we stand?
por: Prodinger, Christine, et al.
Publicado: (2020) -
Clinical Perspectives of Gene-Targeted Therapies for Epidermolysis Bullosa
por: Welponer, Tobias, et al.
Publicado: (2021) -
Profiling trial burden and patients’ attitudes to improve clinical research in epidermolysis bullosa
por: Prodinger, Christine, et al.
Publicado: (2020) -
Epidermolysis bullosa House Austria and Epidermolysis bullosa clinical network: Example of a centre of expertise implemented in a European reference network to face the burden of a rare disease
por: Laimer, Martin, et al.
Publicado: (2016) -
Growth profile and anaemia in children with epidermolysis bullosa
por: Laimer, M.
Publicado: (2019)